chr2-178747098-T-C

Variant summary

Our verdict is Likely benign. The variant received -5 ACMG points: 0P and 5B. BP4_StrongBP6

The NM_133379.5(TTN):​c.15302A>G​(p.Glu5101Gly) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000375 in 1,610,036 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 13/17 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).

Frequency

Genomes: 𝑓 0.00025 ( 0 hom., cov: 32)
Exomes 𝑓: 0.00039 ( 0 hom. )

Consequence

TTN
NM_133379.5 missense

Scores

1
2
12

Clinical Significance

Conflicting classifications of pathogenicity criteria provided, conflicting classifications U:2B:2

Conservation

PhyloP100: 1.07

Publications

3 publications found
Variant links:
Genes affected
TTN (HGNC:12403): (titin) This gene encodes a large abundant protein of striated muscle. The product of this gene is divided into two regions, a N-terminal I-band and a C-terminal A-band. The I-band, which is the elastic part of the molecule, contains two regions of tandem immunoglobulin domains on either side of a PEVK region that is rich in proline, glutamate, valine and lysine. The A-band, which is thought to act as a protein-ruler, contains a mixture of immunoglobulin and fibronectin repeats, and possesses kinase activity. An N-terminal Z-disc region and a C-terminal M-line region bind to the Z-line and M-line of the sarcomere, respectively, so that a single titin molecule spans half the length of a sarcomere. Titin also contains binding sites for muscle associated proteins so it serves as an adhesion template for the assembly of contractile machinery in muscle cells. It has also been identified as a structural protein for chromosomes. Alternative splicing of this gene results in multiple transcript variants. Considerable variability exists in the I-band, the M-line and the Z-disc regions of titin. Variability in the I-band region contributes to the differences in elasticity of different titin isoforms and, therefore, to the differences in elasticity of different muscle types. Mutations in this gene are associated with familial hypertrophic cardiomyopathy 9, and autoantibodies to titin are produced in patients with the autoimmune disease scleroderma. [provided by RefSeq, Feb 2012]
TTN-AS1 (HGNC:44124): (TTN antisense RNA 1) This gene encodes a non-coding RNA transcribed from the opposite strand to the titin gene. [provided by RefSeq, Aug 2016]

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Likely_benign. The variant received -5 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.057745993).
BP6
Variant 2-178747098-T-C is Benign according to our data. Variant chr2-178747098-T-C is described in ClinVar as Conflicting_classifications_of_pathogenicity. ClinVar VariationId is 229587.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
TTNNM_133379.5 linkc.15302A>G p.Glu5101Gly missense_variant Exon 46 of 46 ENST00000360870.10 NP_596870.2 Q8WZ42-6Q7Z3B7
TTNNM_001267550.2 linkc.11312-5177A>G intron_variant Intron 47 of 362 ENST00000589042.5 NP_001254479.2 A0A0A0MTS7

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
TTNENST00000360870.10 linkc.15302A>G p.Glu5101Gly missense_variant Exon 46 of 46 5 NM_133379.5 ENSP00000354117.4 Q8WZ42-6
TTNENST00000589042.5 linkc.11312-5177A>G intron_variant Intron 47 of 362 5 NM_001267550.2 ENSP00000467141.1 A0A0A0MTS7

Frequencies

GnomAD3 genomes
AF:
0.000251
AC:
38
AN:
151548
Hom.:
0
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.0000970
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.000501
Gnomad OTH
AF:
0.00
GnomAD2 exomes
AF:
0.000229
AC:
57
AN:
249432
AF XY:
0.000200
show subpopulations
Gnomad AFR exome
AF:
0.000126
Gnomad AMR exome
AF:
0.000175
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.000416
Gnomad OTH exome
AF:
0.000331
GnomAD4 exome
AF:
0.000388
AC:
566
AN:
1458370
Hom.:
0
Cov.:
34
AF XY:
0.000385
AC XY:
279
AN XY:
725586
show subpopulations
African (AFR)
AF:
0.0000304
AC:
1
AN:
32944
American (AMR)
AF:
0.000202
AC:
9
AN:
44516
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
26026
East Asian (EAS)
AF:
0.00
AC:
0
AN:
39606
South Asian (SAS)
AF:
0.00
AC:
0
AN:
86106
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
53310
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
5740
European-Non Finnish (NFE)
AF:
0.000481
AC:
534
AN:
1109932
Other (OTH)
AF:
0.000366
AC:
22
AN:
60190
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.468
Heterozygous variant carriers
0
40
81
121
162
202
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Variant carriers
0
22
44
66
88
110
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.000251
AC:
38
AN:
151666
Hom.:
0
Cov.:
32
AF XY:
0.000256
AC XY:
19
AN XY:
74134
show subpopulations
African (AFR)
AF:
0.0000967
AC:
4
AN:
41366
American (AMR)
AF:
0.00
AC:
0
AN:
15216
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3452
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5116
South Asian (SAS)
AF:
0.00
AC:
0
AN:
4806
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
10608
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
292
European-Non Finnish (NFE)
AF:
0.000501
AC:
34
AN:
67812
Other (OTH)
AF:
0.00
AC:
0
AN:
2090
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.499
Heterozygous variant carriers
0
2
4
6
8
10
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.000383
Hom.:
0
Bravo
AF:
0.000268
TwinsUK
AF:
0.00
AC:
0
ALSPAC
AF:
0.000259
AC:
1
ESP6500AA
AF:
0.000227
AC:
1
ESP6500EA
AF:
0.000349
AC:
3
ExAC
AF:
0.000198
AC:
24
EpiCase
AF:
0.000382
EpiControl
AF:
0.000237

ClinVar

Significance: Conflicting classifications of pathogenicity
Submissions summary: Uncertain:2Benign:2
Revision: criteria provided, conflicting classifications
LINK: link

Submissions by phenotype

not specified Uncertain:1Benign:1
Apr 09, 2025
Molecular Diagnostic Laboratory for Inherited Cardiovascular Disease, Montreal Heart Institute
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Oct 30, 2015
Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

The p.Glu5101Gly variant in TTN has not been previously reported in individuals with cardiomyopathy, but has been identified in 21/66452 European chromosomes by the Exome Aggregation Consortium (ExAC, http://exac.broadinstitute.org; dbSNP r s142973956). Computational prediction tools and conservation analysis are limite d or unavailable for this variant. In summary, the clinical significance of the p.Glu5101Gly variant is uncertain. -

not provided Uncertain:1Benign:1
-
Department of Pathology and Laboratory Medicine, Sinai Health System
Significance:Uncertain significance
Review Status:no assertion criteria provided
Collection Method:clinical testing

The TTN p.Glu5101Gly variant was not identified in the literature nor was it identified in Cosmic or LOVD 3.0. The variant was identified in dbSNP (ID: rs142973956) and in ClinVar (classified as VUS by Laboratory for Molecular Medicine, Partners HealthCare Personalized Medicine). The variant was also identified in control databases in 60 of 280694 chromosomes at a frequency of 0.000214 (Genome Aggregation Database Feb 27, 2017). The variant was observed in the following populations: European (non-Finnish) in 49 of 128338 chromosomes (freq: 0.000382), Other in 2 of 7130 chromosomes (freq: 0.000281), Latino in 6 of 35192 chromosomes (freq: 0.000171) and African in 3 of 24590 chromosomes (freq: 0.000122); it was not observed in the Ashkenazi Jewish, East Asian, European (Finnish), and South Asian populations. Computational protein prediction programs (PolyPhen-2, MutationTaster, BLOSUM) provide inconsistent predictions regarding the impact to the protein. The variant occurs outside of the splicing consensus sequence and in silico or computational prediction software programs (SpliceSiteFinder, MaxEntScan, NNSPLICE, GeneSplicer) do not predict a difference in splicing. In summary, based on the above information the clinical significance of this variant cannot be determined with certainty at this time. This variant is classified as a variant of uncertain significance. -

Jun 04, 2019
GeneDx
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_addAF
Benign
-0.37
T
BayesDel_noAF
Benign
-0.45
CADD
Benign
12
DANN
Uncertain
1.0
Eigen
Benign
-0.10
Eigen_PC
Benign
0.035
FATHMM_MKL
Uncertain
0.89
D
LIST_S2
Benign
0.75
T
M_CAP
Benign
0.0057
T
MetaRNN
Benign
0.058
T
MetaSVM
Benign
-0.92
T
PhyloP100
1.1
PROVEAN
Benign
-0.77
N
REVEL
Benign
0.089
Sift
Pathogenic
0.0
D
Sift4G
Benign
0.30
T
Polyphen
0.0050
B
Vest4
0.46
MVP
0.58
ClinPred
0.084
T
GERP RS
4.4
Mutation Taster
=96/4
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs142973956; hg19: chr2-179611825; API